oral glutathione dosage for parkinson's Revamping disease therapy using PLGA-based drug delivery systems Glutathione (GSH): Clinical Dosing, Pharmacology,
Description
Lancet 380 , 660667 (2012)
F.SalmanK
doi: 10.1053/j.gastro.2010.03.036, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar] Salama N
Urinary magnesium wasting is the major adverse renal effect of anti-EGFR agents
Vascular endothelial growth factors (VEGFs) and stroke
